• 0 items in quote

    No products in the Quote Basket.

  • Portrazza (necitumumab) 800mg/50ml

    Quantity

    Get it to United States within 10 working days with standard delivery.

    Fast delivery to United States

    Easy Returns & Exchanges

    Ask About This Product

    Condition : New

    0

    From UAE

    To United States

    in 5-10 days

    Description

    How it Works: Portrazza (Necitumumab) is a monoclonal antibody used in combination with chemotherapy to treat metastatic squamous non-small cell lung cancer (NSCLC). Necitumumab targets the epidermal growth factor receptor (EGFR) on cancer cells. By binding to EGFR, it blocks the receptor’s activity, thereby slowing or stopping the growth and spread of cancer cells.

    Side Effects:

    • Common Side Effects:
      • Rash
      • Hypomagnesemia (low magnesium levels)
    • Serious Side Effects:
      • Cardiopulmonary arrest (sudden stop of heart and breathing)
      • Blood clots in veins and arteries
      • Severe infusion-related reactions (allergic reactions)
      • Dermatologic toxicities (skin reactions)
      • Embryo-fetal toxicity (harm to an unborn baby)

        Indications:

        Portrazza is indicated for the first-line treatment of metastatic squamous non-small cell lung cancer in combination with chemotherapy drugs gemcitabine and cisplatin. It is not approved for non-squamous NSCLC.

        Contraindications:

        • Known allergy to necitumumab or any of its components
        • Severe infusion-related reactions from previous treatments
        • Pregnancy (due to embryo-fetal toxicity)
        • Severe pre-existing cardiovascular diseases due to an increased risk of heart attack or stroke​.

          Price in Different Countries:

    Country Price (USD) Reference
    United States $5,000 per vial GoodRx
    United Kingdom £4,200 per vial NHS
    Germany €4,500 per vial Medizinfuchs
    Canada $6,200 per vial CanadaDrug
    India ₹320,000 per vial 1mg

    Top 5 Global Brands for Monoclonal Antibody Therapies:

    1. Herceptin (Trastuzumab) – for breast cancer
    2. Keytruda (Pembrolizumab) – for various cancers, including lung cancer
    3. Opdivo (Nivolumab) – for lung and kidney cancers
    4. Avastin (Bevacizumab) – for colorectal and lung cancers
    5. Rituxan (Rituximab) – for blood cancers and autoimmune diseases
    Shopping Cart